Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies

QR Code

Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies

Aim. To study the significance of clinical and laboratory non-invasive indexes along with the insulin resistance index when carrying out diagnostic assessment of non-alcoholic fatty liver disease (NAFLD) during screening examinations. Materials and methods. The study involved 348 employees workin...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Aleksandr E. Nosov, Mariia T. Zenina, Olga Y. Gorbushina, Anastasiia S. Baidina, Elena M. Vlasova, Vadim B. Alekseev
Format:	article
Langue:	RU
Publié:	"Consilium Medicum" Publishing house 2021
Sujets:	non-alcoholic fatty liver disease ultrasound scanning of the liver insulin resistance steatosis indexes Medicine R
Accès en ligne:	https://doaj.org/article/3cee5aaa82a146e1aca7ea4069fc4b81
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Body Mass Index and Indicators of Lipid Exchange in Liver Steatosis of Alcoholic and Nonalcoholic Genesis in Residents of Rural Area: Similarities and Differences
par: N. V. Mikhaylova, et autres
Publié: (2019)

Non-Alcoholic Fatty Liver Disease and Hypothyroidism: Review of Clinical and Experimental Studies
par: Tetiana Ranhulova
Publié: (2021)

Cytoprotective and suicidal signaling in oxidative stress
par: Videla,Luis A
Publié: (2010)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
par: T. E. Promenasheva, et autres
Publié: (2014)

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
par: Pegah Golabi, et autres
Publié: (2022)

Biochemical assessment of metabolic associated fatty liver disease
par: Guerra-Ruiz Armando R., et autres
Publié: (2021)

Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice
par: Li L, et autres
Publié: (2021)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress
par: Sue Shea, et autres
Publié: (2021)

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease
par: Chen L, et autres
Publié: (2020)

Non-Alcoholic Fatty Liver Disease as a Risk for Colorectal Cancer Development and the Role of Screening Colonoscopy in Clinical Practice
par: Cosmas Rinaldi Adithya Lesmana, et autres
Publié: (2019)

Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome
par: Aleksandr I. Pavlov, et autres
Publié: (2021)

Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
par: Satoru Hagiwara, et autres
Publié: (2021)

Alteraciones de la tolerancia a la glucosa y frecuencia de síndrome metabólico en pacientes con enfermedad por hígado graso no alcohólico
par: Araya Q,A. Verónica, et autres
Publié: (2006)

DHA Protects Against Hepatic Steatosis by Activating Sirt1 in a High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Mouse Model
par: Luo X, et autres
Publié: (2020)

Correlation Between COVID-19 Severity, Body Mass Index and Radiological Hepatic Morphology
par: Qandeel,Haitham, et autres
Publié: (2021)

Emerging roles for stress kinase p38 and stress hormone fibroblast growth factor 21 in NAFLD development
par: Junli Liu, et autres
Publié: (2021)

SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions
par: Gharaibeh NE, et autres
Publié: (2019)

The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
par: Hao Xu, et autres
Publié: (2021)

Adiponutrin and Adiponectin Gene Variants in Indonesian Patients with Non-Alcoholic Fatty Liver Disease: a Preliminary Study
par: Rayvita AN Meagratia, et autres
Publié: (2021)

Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial
par: Soleimani D, et autres
Publié: (2020)

Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease
par: Shida T, et autres
Publié: (2019)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
par: Mao YQ, et autres
Publié: (2016)

Electromagnetic Fields Ameliorate Insulin Resistance and Hepatic Steatosis by Modulating Redox Homeostasis and SREBP-1c Expression in db/db Mice
par: Zhai M, et autres
Publié: (2021)

Current concepts of the pathogenesis of non-alcoholic fatty liver disease
par: Evgenia Pavlovna Kosobyan, et autres
Publié: (2010)

Relationship between Adipokines and Cardiovascular Ultrasound Parameters in Metabolic-Dysfunction-Associated Fatty Liver Disease
par: Abdulrahman Ismaiel, et autres
Publié: (2021)

Non-invasive Diagnostics of Liver Fibrosis
par: Mihaylov R., et autres
Publié: (2017)

Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis
par: Lauszus JS, et autres
Publié: (2021)

Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
par: Daniela Maria Tanase, et autres
Publié: (2021)

Significant Association Between Left Ventricular Diastolic Dysfunction, Left Atrial Performance and Liver Stiffness in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
par: Parvanescu T, et autres
Publié: (2021)

Reduced steatosis and weight as a result of specific diets or the dietitian themselves
par: Hirsh D. Trivedi, et autres
Publié: (2021)

Rol de la microbiota intestinal en el desarrollo del hígado graso no alcohólico
par: Tumani,María Fernanda, et autres
Publié: (2021)

Análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólica
par: Lanuza,Fabian, et autres
Publié: (2018)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
par: Siyu Yu, et autres
Publié: (2021)

Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study
par: Zhi-Qin Xie, et autres
Publié: (2021)

Hepatic Response of Magnesium-Restricted Wild Type Mice
par: Vera H. Fengler, et autres
Publié: (2021)

Association of insulin resistance and non-alcoholic fatty liver disease
par: Ekaterina E. Mishina, et autres
Publié: (2021)

Verapamil induces autophagy to improve liver regeneration in non-alcoholic fatty liver mice
par: Jian-Lin Lai, et autres
Publié: (2021)

Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry
par: Alswat K, et autres
Publié: (2021)

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT
par: Ana Šinkovec, et autres
Publié: (2021)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
par: Jin Feng, et autres
Publié: (2021)